JENBURKT PHARMACEUTICALS
Back to Cashflow Statement
|
JENBURKT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹27 Cr | ₹28 Cr | ₹8.12 Cr | ₹17 Cr | ₹9.27 Cr |
What is the latest Cash Flow from Operating Activities ratio of JENBURKT PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹27 Cr |
| Mar2025 | ₹28 Cr |
| Mar2024 | ₹8.12 Cr |
| Mar2023 | ₹17 Cr |
| Mar2022 | ₹9.27 Cr |
How is Cash Flow from Operating Activities of JENBURKT PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹27 Cr | -4.96 | |
| Mar2025 | ₹28 Cr | 243.50 | |
| Mar2024 | ₹8.12 Cr | -52.36 | |
| Mar2023 | ₹17 Cr | 83.93 | |
| Mar2022 | ₹9.27 Cr | - | |
Compare Cash Flow from Operating Activities of peers of JENBURKT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JENBURKT PHARMACEUTICALS | ₹431.2 Cr | 3.9% | 6% | -20.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,707.0 Cr | 1.4% | 6.7% | 12% | Stock Analytics | |
| DIVIS LABORATORIES | ₹303,962.0 Cr | 11.1% | 23.5% | 70% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹179,494.0 Cr | 1% | 1.8% | 34.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,769.0 Cr | 1.1% | 11.8% | 14.2% | Stock Analytics | |
| CIPLA | ₹113,912.0 Cr | 0.1% | 6% | -5.8% | Stock Analytics | |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JENBURKT PHARMACEUTICALS | 3.9% |
6% |
-20.8% |
| SENSEX | 3.3% |
13.9% |
-1.7% |
You may also like the below Video Courses